Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan

Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an anti-neuronal antibody-mediated inflammatory brain disease that causes severe psychiatric and neurological deficits in previously healthy patients. The aims of this study were to demonstrate the clinical characteristics of patients diagnosed with anti-NMDA receptor encephalitis and to compare the different treatment strategies among these patients.

Source: Pediatrics and Neonatology - November 15, 2018 Category: Perinatology & Neonatology Authors: Shu-Sing Kong, Yun-Ju Chen, I-Chen Su, Jainn-Jim Lin, I-Jun Chou, Min-Liang Chou, Po-Cheng Hung, Meng-Ying Hsieh, Yi-Shan Wang, Cheng-Che Chou, Huei-Shyong Wang, Kuang-Lin Lin, the CHEESE Study Group Tags: Original Article Source Type: research